Research Purposes Only

Selank 10mg (Selank peptide) lyophilised research peptide vial — UK lab-tested, for research use only

CNS Research Peptides

Selank

10mg

C₃₃H₅₇N₁₁O₉

Key Research Findings

  • Characterisation of the tuftsin-derived heptapeptide sequence.
  • Published rodent BDNF transcription assay data.
  • In-vitro IL-6 cytokine modulation studies.

Overview

Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin. Supplied as a lyophilised powder for in-vitro research use only.

Mechanism of Action

Reported in published in-vitro and animal-model studies to interact with the GABAergic system and to modulate BDNF transcription in cell-line assays. Not intended for human or veterinary use.

Research Effects

GABAergic Modulation Studies

Extensive Research

Reported in animal-model studies as a modulator of GABA receptor pathway activity.

BDNF Transcription Studies

Moderate Research

Published cell-culture assays report effects on BDNF gene transcription.

Cytokine-Expression Studies

Moderate Research

In-vitro studies report modulation of IL-6 and related cytokines in macrophage assays.

Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.

Quick Facts

Molecular FormulaC₃₃H₅₇N₁₁O₉
Molecular Weight751.88 g/mol
CAS Number129954-34-3
SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin analogue)
Half-Life~2–3 min (animal pharmacokinetic data)
SolubilityWater (1 mg/mL)
Storage−20 °C
More in CNS Research Peptides

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Featured in Bundles

Selank is included in the following Zenterex research peptide bundles.

Related Peptides

How can we help?
Cart